Hide metadata

dc.date.accessioned2022-06-10T15:43:12Z
dc.date.available2022-06-10T15:43:12Z
dc.date.created2022-05-13T13:35:36Z
dc.date.issued2022
dc.identifier.citationMoe, Fredrik Dreyer Berg, Henrik . Treating equivalent cases differently: A comparative analysis of substance use disorder and type 2 diabetes in Norwegian treatment guidelines. Journal of Evaluation In Clinical Practice. 2022, 1-8
dc.identifier.urihttp://hdl.handle.net/10852/94348
dc.description.abstractBackground Substance use disorder (SUD) is often understood as a chronic illness. Aims: This paper investigates whether SUD is treated as a chronic illness. Method To this aim, we have used World Health Organizations (WHO's) definition of chronic illness to conduct a comparative analysis of SUD and type 2 diabetes (T2D), which is another chronic illness. Results When analysing Norwegian treatment guidelines, we found that only the T2D guideline reflects the WHO's conceptualization of chronic illnesses. We argue that this discrepancy implies that SUD is understood as a moral and legal problem, while T2D is conceptualized as a somatic illness. We discuss how social, political and historical conditions of the possibility for understanding SUD are interwoven with normative presumptions about the clinician, patient, treatment guidelines and drug policies in a way that may impede the development of continuing care. Conclusion The paper concludes that the delivery of treatment services is inequitable as SUD is not treated as a chronic illness.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleTreating equivalent cases differently: A comparative analysis of substance use disorder and type 2 diabetes in Norwegian treatment guidelines
dc.title.alternativeENEngelskEnglishTreating equivalent cases differently: A comparative analysis of substance use disorder and type 2 diabetes in Norwegian treatment guidelines
dc.typeJournal article
dc.creator.authorMoe, Fredrik Dreyer
dc.creator.authorBerg, Henrik
cristin.unitcode185,50,1,14
cristin.unitnameHelsevitenskapelig utdanningssenter
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2024388
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal of Evaluation In Clinical Practice&rft.volume=&rft.spage=1&rft.date=2022
dc.identifier.jtitleJournal of Evaluation In Clinical Practice
dc.identifier.startpage1
dc.identifier.endpage8
dc.identifier.doihttps://doi.org/10.1111/jep.13693
dc.identifier.urnURN:NBN:no-96886
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn1356-1294
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/94348/1/Evaluation%2BClinical%2BPractice%2B-%2B2022%2B-%2BMoe%2B-%2BTreating%2Bequivalent%2Bcases%2Bdifferently%2B%2BA%2Bcomparative%2Banalysis%2Bof%2Bsubstance%2Buse.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International